Patisiran is beneficial for the treatment of TTR cardiac amyloidosis.

Nat Rev Cardiol

Nature Reviews Cardiology, .

Published: January 2024

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41569-023-00955-2DOI Listing

Publication Analysis

Top Keywords

patisiran beneficial
4
beneficial treatment
4
treatment ttr
4
ttr cardiac
4
cardiac amyloidosis
4
patisiran
1
treatment
1
ttr
1
cardiac
1
amyloidosis
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!